Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you
ALERT

Find out How Index Funds are Traded, Priced & Potential Issues You May Face

Mutualfunds logo

FPHAX Fidelity® Select Pharmaceuticals Port

  • Fund
  • FPHAX
  • Price as of: Jul 19, 2017
  • $19.21
  • + $0.06
  • + 0.31%
  • Category
  • Health & Biotech Equities

FPHAX - Profile

Vitals

  • YTD Return 12.7%
  • 3 Yr Annualized Return 3.0%
  • 5 Yr Annualized Return 13.3%
  • Net Assets $955 M
  • Holdings in Top 10 65.8%

52 WEEK LOW AND HIGH

$19.21
$16.57
$20.16

Expenses

OPERATING RELATED FEES

  • Expense Ratio 0.80%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 77.00%

TRADING FEES

  • Max Redemption Fee 0.75%

Min Investment

STANDARD (TAXABLE)

$2,500

IRA

$2,500

Investment Themes

CATEGORY

Health & Biotech Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return 12.7%
  • 3 Yr Annualized Total Return 3.0%
  • 5 Yr Annualized Total Return 13.3%
  • Capital Gain Distribution Frequency Semi-Annually
  • Net Income Ratio 1.16%
DIVIDENDS
  • Dividend Yield 0.2%
  • Dividend Distribution Frequency Semi-Annually

Fund Details

  • Legal Name Fidelity® Select Pharmaceuticals Portfolio
  • Fund Family Name Fidelity Investments
  • Inception Date Jun 18, 2001
  • Shares Outstanding N/A
  • Share Class No Load
  • Currency USD
  • Domiciled Country United States
  • Manager Asher Anolic

Fund Description

The Fidelity Select Pharmaceuticals Portfolio (FPHAX) is an actively managed fund that focuses on the health care sector. FPHAX hones in on those firms that research and develop drugs, including traditional pharmaceutical firms and biotech drug makers. The fund can hold domestic or foreign stocks of any size. FPHAX’s managers focus on innovation as well as profits when selecting the fund’s underlying portfolio.

Despite its low costs, FPHAX’s extremely narrow focus places it in the satellite position camp within a broader equity portfolio. The fund is run by several Fidelity offices.

FPHAX - Performance

Return Ranking - Trailing

Period FPHAX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD 12.7% -14.9% 31.1% 89.29% 5
1 Yr 1.8% -14.8% 43.3% 97.30% 5
3 Yr 3.0% * -7.5% 18.2% 98.15% 5
5 Yr 13.3% * 9.3% 21.8% 94.17% 5
10 Yr 10.3% * 6.1% 15.7% 65.66% 4

* Annualized


Return Ranking - Calendar

Period FPHAX Return Category Return Low Category Return High Rank in Category (%) Quintile
2016 -17.2% -29.8% 2.6% 62.73% 4
2015 -3.8% -20.4% 14.5% 60.91% 4
2014 11.3% -5.8% 33.7% 66.36% 4
2013 27.7% -2.6% 65.2% 79.82% 4
2012 10.8% -5.3% 36.5% 61.17% 4

Total Return Ranking - Trailing

Period FPHAX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD 12.7% -14.9% 31.1% 90.09% 5
1 Yr 1.8% -18.3% 41.2% 94.55% 5
3 Yr 3.0% * -14.2% 18.2% 93.52% 5
5 Yr 13.3% * 9.1% 21.8% 92.23% 5
10 Yr 10.3% * 6.1% 15.7% 59.60% 3

* Annualized


Total Return Ranking - Calendar

Period FPHAX Return Category Return Low Category Return High Rank in Category (%) Quintile
2016 -17.2% -25.1% 6.3% 65.14% 4
2015 9.5% -16.6% 39.1% 29.36% 2
2014 30.4% -5.8% 100.0% 63.30% 4
2013 73.9% -5.1% 398.7% 56.48% 3
2012 30.4% -2.6% 475.8% 70.00% 4

NAV & Total Return History

FPHAX - Holdings

Filings data as of: May 31, 2017

Concentration Analysis

FPHAX Category Low Category High FPHAX % Rank Quintile
Net Assets 955 M 20.8 M 48.3 B 18.75% 4
Number of Holdings 59 32 365 24.11% 5
Net Assets in Top 10 624 M 9.25 M 20.1 B 14.29% 2
Weighting of Top 10 65.8% 19.5% 71.8% 1.79% 1

Top 10 Holdings

  1. Allergan PLC 6.34%
  2. Bristol-Myers Squibb Company 4.14%
  3. Johnson & Johnson 12.40%
  4. Sanofi SA ADR 9.72%
  5. GlaxoSmithKline PLC ADR 9.61%
  6. AstraZeneca PLC ADR 6.11%
  7. Merck & Co Inc 3.61%
  8. Novartis AG ADR 4.90%
  9. Pfizer Inc 6.38%
  10. Roche Holding AG Dividend Right Cert. 2.62%

Asset Allocation

Weighting Category Low Category High FPHAX % Rank Quintile
Stocks
100.05% 85.65% 102.85% 1.79% 1
Preferred Stocks
0.00% 0.00% 0.71% 5.36% 4
Other
0.00% -11.71% 7.50% 16.07% 4
Convertible Bonds
0.00% 0.00% 0.49% 3.57% 4
Bonds
0.00% 0.00% 5.97% 4.46% 4
Cash
-0.06% -0.06% 14.35% 30.36% 5

Stock Sector Breakdown

Weighting Category Low Category High FPHAX % Rank Quintile
Healthcare
98.97% 11.52% 99.64% 3.57% 1
Consumer Defense
1.08% 0.00% 2.14% 7.14% 1
Utilities
0.00% 0.00% 1.11% 1.79% 4
Technology
0.00% 0.00% 64.38% 26.79% 5
Real Estate
0.00% 0.00% 1.50% 2.68% 4
Industrials
0.00% 0.00% 8.05% 10.71% 4
Financial Services
0.00% 0.00% 5.16% 6.25% 4
Energy
0.00% 0.00% 0.00% 0.89% 4
Communication Services
0.00% 0.00% 0.00% 0.89% 4
Consumer Cyclical
0.00% 0.00% 5.10% 6.25% 4
Basic Materials
0.00% 0.00% 1.96% 4.46% 4

Stock Geographic Breakdown

Weighting Category Low Category High FPHAX % Rank Quintile
US
59.77% 59.77% 99.64% 35.71% 5
Non US
40.28% 0.00% 40.28% 0.89% 1

FPHAX - Expenses

Operational Fees

FPHAX Fees (% of AUM) Category Low Category High Rank in Category (%) Quintile
Expense Ratio 0.80% 0.10% 4.31% 64.29% 1
Management Fee 0.55% 0.09% 1.25% 14.29% 1
12b-1 Fee N/A 0.00% 1.00% N/A N/A
Administrative Fee N/A 0.01% 0.40% N/A N/A

Sales Fees

FPHAX Fees (% of AUM) Category Low Category High FPHAX Rank Quintile
Front Load N/A 3.50% 5.75% N/A N/A
Deferred Load N/A 1.00% 5.00% N/A N/A

Trading Fees

FPHAX Fees (% of AUM) Category Low Category High FPHAX Rank Quintile
Max Redemption Fee 0.75% 0.75% 2.00% 6.82% 1

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

FPHAX Fees (% of AUM) Category Low Category High FPHAX Rank Quintile
Turnover 77.00% 0.00% 699.00% 8.04% 5

FPHAX - Distributions

Dividend Yield Analysis

FPHAX Category Low Category High FPHAX % Rank Quintile
Dividend Yield 0.2% 0.01% 0.94% 19.15% 1

Dividend Distribution Analysis

FPHAX Category Low Category High Category Mode
Dividend Distribution Frequency Semi-Annually Annually Quarterly Annually

Dividend Payout History


Net Income Ratio Analysis

FPHAX Category Low Category High FPHAX % Rank Quintile
Net Income Ratio 1.16% -2.22% 1.40% 1.79% 1

Capital Gain Distribution Analysis

FPHAX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Semi-Annually Annually Semi-Annually Annually

FPHAX - Managers

Asher Anolic

Manager

Start Date

Apr 10, 2013

Tenure

4.22

Tenure Rank

16.0%

Since joining Fidelity Investments in 2008, Mr. Anolic has worked as a research analyst and portfolio manager. Prior to joining Fidelity Investments in 2008, Mr. Anolic worked for Bear Stearns as a research analyst.


Karim Suwwan de Felipe

Manager

Start Date

Jul 01, 2017

Tenure

0.0

Tenure Rank

26.7%

Since joining Fidelity Investments in 2010, Mr. Suwwan de Felipe has worked as a research analyst and portfolio manager.


Tenure Analysis

Category Low

0.0

Category High

19.8

Category Average

8.78

Category Mode

2.5